Intestinal Absorption of Calcium in Greyhounds: The Response to Intermittent and Continuous Administration of Human Synthetic Parathyroid Hormone Fragment 1–34 (Hpth 1–34)

1984 ◽  
Vol 67 (6) ◽  
pp. 591-599 ◽  
Author(s):  
R. D. Podbesek ◽  
E. B. Mawer ◽  
G. D. Zanelli ◽  
J. A. Parsons ◽  
J. Reeve

1. Long-term studies of gastrointestinal radio-calcium absorption were undertaken in adult greyhounds before and during two treatment regimes with human parathyroid hormone fragment 1–34 (hPTH 1–34). The results were correlated with plasma vitamin D metabolite levels and kinetic indices related to the balance of fluxes of calcium between plasma and the rapidly exchangeable calcium pools of bone. 2. Compared with adult man, results obtained before treatment started showed lower indices of gastrointestinal calcium absorption and considerably higher concentrations of 24-hydroxycalcidiol in the dogs. 3. Daily injections of hPTH 1–34 at 1.7 μg day−1 kg−1 significantly increased indices of radiocalcium absorption and plasma calcitriol concentrations, while only causing transient calcaemic responses. The individual magnitudes of the calcaemic response correlated positively with indices of radiocalcium retention in the exchangeable pools of bone which in turn correlated positively with ‘late-phase’ absorption of radiocalcium from the gut. 4. Subcutaneous infusions of hPTH 1–34 at 0.5 μg day−1 kg−1 to the same dogs were just insufficient to cause hypercalcaemia, but increased plasma calcitriol concentrations. Indices of radiocalcium absorption were not increased. 5. Continuous parathyroid hormone (PTH) infusion is now known to substantially down-regulate renal PTH receptor density, whereas recovery after a brief exposure to PTH occurs within 24 h. It is possible that the differences in response of the gut to the two regimes may in part be related to their differing effects on some PTH receptors.

PEDIATRICS ◽  
1975 ◽  
Vol 55 (6) ◽  
pp. 751-753
Author(s):  
Henry L. Nadler

During the past two decades, a number of dramatic changes have taken place in the treatment of infants born with myelomenmgocele. Since the development in the 1950's and early 1960's of more effective methods for treating hydrocephalus, urinary incontinence, and paraplegia, aggressive treatment regimes have been initiated. Numerous articles and editorials have questioned these various treatment modalities based on the lack of objective long-term studies documenting their effectiveness. More recently, dissatisfaction with the results of current surgical prodecures for children with myelomeningocele has led to the development of selective criteria for early treatment.1,2 The purpose of this commentary, however, is not to discuss the merits of selective treatment for myelomeningocele but rather to discuss some of the recent developments for the prevention of this disorder.


Author(s):  
Cecilia D'angelo ◽  
Jörg Wiedenmann

Molecular biological methods including genomic and proteomic approaches hold a specific promise to provide new insights into the stress physiology of corals. However, to fully exploit the power of these techniques, aquarium setups are required that allow biological assays under tightly controlled laboratory conditions. Here, details are provided about the successful development of a closed coral mesocosm at the National Oceanography Centre, Southampton. The system can be operated without access to natural seawater and allows long-term observations and experimental studies of reef corals. The individual experimental tanks allow the corals to be exposed, for example, to different light and/or temperature conditions without the need to disconnect them from the system.


2012 ◽  
Vol 37 (3) ◽  
pp. 617-629 ◽  
Author(s):  
Atsushi Watanabe ◽  
Shigeki Yoneyama ◽  
Mikio Nakajima ◽  
Norihiro Sato ◽  
Ryoko Takao-Kawabata ◽  
...  

Endocrinology ◽  
1983 ◽  
Vol 112 (3) ◽  
pp. 1000-1006 ◽  
Author(s):  
R. PODBESEK ◽  
C. EDOUARD ◽  
P. J. MEUNIER ◽  
J. A. PARSONS ◽  
J. REEVE ◽  
...  

1988 ◽  
Vol 33 (7) ◽  
pp. 637-644
Author(s):  
Christian L. Shriqui

Tardive Dyskinesia (TD) is a neurological syndrome associated with long-term use of antipsychotic drug treatment (APD). Its significant prevalence (estimated 15–20%) and potential irreversibility are a major concern in psychiatry. The clinical picture is characterized by involuntary repetitive movements of choreoathetotic and dystonic nature varying in location and intensity. The individual outcome of TD is unpredictable but recent long-term studies give reason for prudent optimism. All neuroleptics are involved in the disorder, numerous risk factors have been suggested; advancing age is the only one which has a clearly definite role. Even though several hypotheses have been suggested, the pathophysiology of the disorder remains a mystery. Informed consent is discussed in this update with regard to the legal implications of the disorder. Because of lack of effective treatment, prevention of TD is essential. The present treatment of choice is gradual reduction (and ideally discontinuance) of APD treatment when possible.


Sign in / Sign up

Export Citation Format

Share Document